The majority of the discovery was funded by the National Health and Medical Research Council and part of the work was achieved using facilities at The University of WA based Centre for Microscopy, Characterisation and Analysis.
Earlier this month, a second paper by Associate Professor Ganss and her team was published in The Journal of Clinical Investigation which describes how tumours can be attacked by the immune system with fewer side-effects.
This discovery involves targeting tumours with inflammatory substances that change the environment, so immune cells can attack the tumour through blood vessels more effectively and lessen the amount of toxins going elsewhere in the body, Associate Professor Ganss said.
WAIMR Director Professor Peter Klinken praised Associate Professor Ganss team saying their work was serving to further put WA on the scientific world map.
This breakthrough is one of the most significant discoveries to come out of WAIMR. The potential for this new knowledge to positively impact the lives of cancer patients in the future is very exciting, he said.
The fact that this breakthrough has come during our 10-year anniversary celebrations is just fantastic.
'/>"/>
| Contact: Sarah Hayward sarah@capturemedia.com.au 61-893-889-280 Research Australia Source:Eurekalert |